Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Legend Biotech Corporation Sponsored ADR (LEGN) had Receiveable Turnover of 2.85 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$285.14M |
|
$-518.25M |
|
$144.21M |
|
$140.93M |
|
$697.72M |
|
$-412.57M |
|
$-107.54M |
|
$-520.12M |
|
$-520.12M |
|
$-518.25M |
|
$-518.25M |
|
$-518.25M |
|
$-518.25M |
|
$-412.57M |
|
$-392.12M |
|
176.08M |
|
176.08M |
|
$-2.94 |
|
$-2.94 |
|
| Balance Sheet Financials | |
$1.50B |
|
$108.72M |
|
$350.81M |
|
$1.85B |
|
$216.42M |
|
$281.33M |
|
$380.82M |
|
$597.24M |
|
$1.25B |
|
$1.25B |
|
$1.25B |
|
181.91M |
|
| Cash Flow Statement Financials | |
$-393.28M |
|
$92.79M |
|
$791.49M |
|
$786.03M |
|
$1.28B |
|
$491.68M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.92 |
|
-- |
|
-- |
|
0.18 |
|
0.24 |
|
49.42% |
|
-144.69% |
|
-144.69% |
|
-137.52% |
|
-182.41% |
|
-181.75% |
|
$-413.36M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
7.42 |
|
|
Receiveable Turnover |
2.85 |
128.06 |
|
-41.41% |
|
-41.55% |
|
-28.03% |
|
-33.81% |
|
$6.88 |
|
$-2.35 |
|
$-2.23 |
|